Health Canada

November 15, 2018November 15, 2018

Health Canada Approves Phase 1 Study of Vaporized Cannabinoid-derived Treatment PPP001 for Chronic Pain

News

Tetra BioPharma has announced that the Therapeutic Drug Directorate at Health Canada has issued a “No objection letter” in approving a Phase 1 study to test a vaporized version of PPP001 for ... Read more

September 25, 2018September 25, 2018

Storz & Bickel-Tetra Collaboration on Investigational Inhaled Medical Cannabis Product Moves Forward

News

Tetra Bio-Pharma announced the advancement of its collaboration with Storz & Bickel for the development of a fibromyalgia treatment combining Tetra’s investigational medical cannabis product PPP001 and Storz & Bickel’s ... Read more

October 4, 2017October 4, 2017

Health Canada Approves AVACEN 100 to Treat Pain in Fibromyalgia Patients

Fibromyalgia, News

Avacen Medical recently announced that its Avacen 100 Class II medical device, previously licensed for treating joint pain associated with arthritis, is now licensed by Health Canada to treat generalized ... Read more

May 31, 2017May 31, 2017

Health Canada Approves Avacen’s Non-Drug Treatment Device for Fibromyalgia Pain

News

Avacen Medical says its Avacen 100 Class-II medical pain treatment product has received a medical device license from Health Canada to treat fibromyalgia. The San Diego-based biotech firm’s marquee product uses a non-invasive technique ... Read more

October 5, 2016October 5, 2016

PainX Device for Fibromyalgia Approved in Canada

News

Soterix Medical’s PainX treatment platform, used to ease pain in fibromyalgia patients, has been approved in Canada as an in-office treatment. The therapy includes a non-invasive procedure featuring a mild electric current that ... Read more